Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Aug 12;15(8):e0232305. doi: 10.1371/journal.pone.0232305

The prevalence and genomic context of Shiga toxin 2a genes in E. coli found in cattle

Tomas Jinnerot 1, Angeles Tatiana Ponton Tomaselli 2, Gro Skøien Johannessen 2, Robert Söderlund 1, Anne Margrete Urdahl 2, Anna Aspán 1, Camilla Sekse 2,*
Editor: Patrick Butaye3
PMCID: PMC7423110  PMID: 32785271

Abstract

Shiga toxin-producing Escherichia coli (STEC) that cause severe disease predominantly carry the toxin gene variant stx2a. However, the role of Shiga toxin in the ruminant reservoirs of this zoonotic pathogen is poorly understood and strains that cause severe disease in humans (HUSEC) likely constitute a small and atypical subset of the overall STEC flora. The aim of this study was to investigate the presence of stx2a in samples from cattle and to isolate and characterize stx2a-positive E. coli. In nationwide surveys in Sweden and Norway samples were collected from individual cattle or from cattle herds, respectively. Samples were tested for Shiga toxin genes by real-time PCR and amplicon sequencing and stx2a-positive isolates were whole genome sequenced. Among faecal samples from Sweden, stx1 was detected in 37%, stx2 in 53% and stx2a in 5% and in skin (ear) samples in 64%, 79% and 2% respectively. In Norway, 79% of the herds were positive for stx1, 93% for stx2 and 17% for stx2a. Based on amplicon sequencing the most common stx2 types in samples from Swedish cattle were stx2a and stx2d. Multilocus sequence typing (MLST) of 39 stx2a-positive isolates collected from both countries revealed substantial diversity with 19 different sequence types. Only a few classical LEE-positive strains similar to HUSEC were found among the stx2a-positive isolates, notably a single O121:H19 and an O26:H11. Lineages known to include LEE-negative HUSEC were also recovered including, such as O113:H21 (sequence type ST-223), O130:H11 (ST-297), and O101:H33 (ST-330). We conclude that E. coli encoding stx2a in cattle are ranging from strains similar to HUSEC to unknown STEC variants. Comparison of isolates from human HUS cases to related STEC from the ruminant reservoirs can help identify combinations of virulence attributes necessary to cause HUS, as well as provide a better understanding of the routes of infection for rare and emerging pathogenic STEC.

Introduction

Shiga toxin-producing Escherichia coli (STEC) are zoonotic pathogens, occurring as abundant commensals among ruminants while occasionally causing gastrointestinal disease in humans. STEC infections can lead to the rare, but severe, hemolytic uraemic syndrome (HUS), with children and the elderly being most at risk [1]. HUS can be fatal or lead to long-term sequelae with reduced kidney function or less commonly gastrointestinal or cognitive disabilities [2]. Though STEC constitute a genetically diverse group and all STEC should be considered potential agents of severe human disease [3], certain lineages appear to pose a far higher risk of causing HUS compared to other STEC. These STEC are referred to as HUSEC, i.e. E. coli previously associated with HUS [4]. In addition to the characteristics of the infecting STEC strain, the risk of developing HUS for a given patient is likely to be affected by host factors such as age and immunological status and possibly other factors like inoculum size and route of infection. Nonetheless, the identification of HUSEC strains is valuable for prioritizing interventions to reduce the exposure of humans to the most dangerous forms of STEC and to predict the progression of cases of illness.

STEC carry genes encoding Shiga toxins (Stx), considered to be their primary virulence factor. Stx genes are encoded by lambdoid bacteriophages that are maintained in a lysogenic stage in the bacterial chromosome [5]. Two types of Shiga toxins are known, Stx1 and Stx2, both of which are grouped into several subtypes. The presence of genes encoding a toxin variant referred to as Shiga toxin 2a (encoded by stx2a genes) has been repeatedly shown to be a trait shared by the majority of HUSEC strains [4,6,7]. However, while the presence of stx2a appears to be useful as a marker for the potential to cause HUS for strains infecting humans, the role of Shiga toxin in the ruminant reservoirs of STEC is poorly understood. Therefore, strains that cause severe disease in humans likely constitute a small and atypical subset of the overall STEC flora in ruminants. The prevalence and characteristics of major human pathogenic serotypes like O157:H7 that include known HUSEC have been extensively investigated in many countries over the last decades. Many other virulence-associated genes have been described and intimin (eae) is probably the principal adherence factor in human pathogenic STEC. The intimin gene is encoded on a pathogenicity island called the locus of enterocyte effacement (LEE), a genomic region encoding a system for attachment to the intestinal mucosa and translocation of effector proteins into host cells [3,8]. LEE is common in pathogenic STEC, but not essential for causing severe disease [911]. LEE-negative (eae-negative) STEC strains have also been associated with severe disease such as HUS, and they probably possess alternative mechanisms for attachment, such as aggR described for STEC/EAEC O104:H4 [12] and saa as described for STEC O113:H21 [13]. Few if any studies have been performed with the aim of providing an unbiased and comprehensive view of STEC strains carrying stx2a that occur in ruminant reservoirs. The aim of the present study was 1) to investigate the presence of stx2a genes in cattle samples collected in Norway and Sweden, 2) investigate the presence of stx2 variants in cattle using high throughput amplicon sequencing and 3) characterize recovered stx2a-positive E. coli and relate their phylogeny and virulence characteristics to known HUSEC.

Materials and methods

Development of a real-time PCR for stx2a

A hydrolysis probe based real-time PCR assay for the detection of stx2a (Table 1) with primers containing locked nucleic acids (Exiqon A/S, Vedbaek, Denmark) was developed by alignment of 94 sequences of stx2 representing all the recognised subtypes, 2a through 2g [14]. The novel assay was tested against a panel of E. coli strains obtained from the EU reference laboratory for E. coli (Istituto Superiore di Sanità, Rome, Italy) and from Statens Serum Institut (Copenhagen, Denmark) with known stx1 and stx2 subtypes. The assay was also tested in parallel with conventional PCR for stx2 subtyping according to the reference laboratory [15] on a panel of STEC strains to verify the performance of the method (Table 2). PCR efficiency was assessed by analysing serial dilutions of DNA from the positive control EDL933 in the Swedish lab. DNA concentration was measured using Qubit QuantIT HS kit (Invitrogen, Carlsbad, CA).

Table 1. Primers and hydrolysis probes used in this study for screening of Shiga toxin genes.

Designation Sequence 5’-3’ with modifications* Usage Reference
stx-F TTTGTYACTGTSACAGCWGAAGCYTTACG stx1 and stx2 real-time PCR [16]
stx-R CCCCAGTTCARWGTRAGRTCMACRTC
stx1-probe CY5-CTGGATGATCTCAGTGGGCGTTCTTATGTAA-BHQ2
stx2-probe FAM-TCGTCAGGCACTGTCTGAAACTGCTCC-BHQ1
VT2a-QfLNA GGCGG+TTTT+ATT+TGCATTA+G stx2a real-time PCR This study
VT2a-QrLNA CG+TC+AAC+CTT+CACTGT+A
VT2a-Qp ATTO550-CRCAATCCGCCGCCATTGCATTAACAGAA-BHQ2
F4_ad TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGCACTGTCTGAAACTGCTCCTGT stx2 amplicon sequencinga Modified from Persson et al. [6]
F4f_ad TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCGCTGTCTGAGGCATCTCCGCT
R1_ad GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATTAAACTGCACTTCAGCAAATCC
R1ef_ad GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTAAACTTCACCTGGGCAAAGCC

*Y = C or T, S = G or C, W = A or T, R = A or G, M = A or C

LNA, locked nucleic acid, as indicated by a preceding plus sign in the primer sequence.

a stx2 specific sequences in bold and adapter sequences in italics.

Table 2. Shiga toxin-producing Escherichia coli strains and other E. coli variants for exclusion and inclusion criteria using an stx2a-specific real-time PCR.

Real-time PCR Conventional PCR [15]
Type ID Origin/ Reference stx2a stx2a Other
stx types
Strains tested in the Swedish lab. O26 35989 cattle + + nd
O26 60409 cattle + + nd
O26 56296 human + + nd
O26 56299 human + + nd
O26 11929 human + + nd
O121 93404 cattle + + nd
O121 93671 cattle + + nd
O121 56304 human + + nd
O121 61726 human + + nd
O121 61734 human + + nd
O157 7351 cattle + + nd
O157 7353 cattle + + nd
O157 7881 cattle + + stx2c
SF-O157 73985 human + + nd
O103 61704 human + + nd
O103 6 human + + nd
O104:H4 34474 human + + nd
O157:H7 EDL933 [14] + + stx1a
O121 77173 QA + + nd
O157 77180 QA + + nd
O157 77185 QA + + nd
O48:H21 81459 QA + + stx1a
O103 23866 QA + + nd
O26 77179 QA + + nd
O26 14684 cattle - - nd
O26 2733 cattle - - nd
O157 492 cattle - - stx2c
O157 55439 cattle - - stx2c
O157 52063 cattle - - stx2c
O103 61713 human - - nd
O157 CCUG 42744 REF - - stx1a and stx2c
E. coli ATCC 35218 REF - - nd
O174:H21 81460 QA - - stx2b and stx2c
O118:H12 81462 QA - - stx2b
O73:H18 81463 QA - - stx2d
unknown 81464 QA - - stx2g
ONT:H19 81465 QA - - stx1d
unknown 81466 QA - - stx2f
O174:H8 81467 QA - - stx1c and stx2b
O139:H1 81468 QA - - stx2e
Strains tested in the Norwegian lab O113 51033 minced meat + + stx1a and stx2dact
O157:H7 EDL933 [14] + + stx1a
O48:H21 94C [14] + + stx1c
O146:H21 NVI_257 QA + + -
O157:H7 NVI_856 QA + + stx2c
O26:H11 102–09817 Human + + -
O103:H25 11060424 Human + + -
O26:H11 1107–2514 Human + + -
O26:H11 1107–2561 Human + + -
O145:H28 11101865 Human + + -
O145:H28 11111058 Human + + -
O157:H7 NVI-5768 QA + + stx2c
O121:H19 NVI-6694 QA + + -
O157:H7 NVI-8375 QA + + -
O26:H11 NVI-9669 QA + + -
O145:H25 2013-22-83-1-2 Sheep + + -
O121 NVI-9529 QA + + -
O145 000816 Human + + -
O26:H11 2007-60-10067 Sheep + + -
O26:H11 2007-60-10714 Sheep + + -
O26:H11 2007-60-11809 Sheep + + -
O174:H8 DG131/3 [14] - - stx1c and stx2b
O118:H12 EH250 [14] - - stx2b
O174:H21 31 [14] - - stx2b and stx2c
O73:H18 C165-02 [14] - - stx2d
O139:H1 S1191 [14] - - stx2e
O128ac:H2 T4/97 [14] - - stx2f
O2:H25 7v [14] - - stx2g
O171:H2 NVI-136 QA - - stx2b and stx2c and stx2d
O145:H34 NVI-298 QA - - stx2f
O139:H1 NVI-427 QA - - stx2e
O2:H25 NVI-937 QA - - stx2g
O22:H8 NVI-949 QA - - stx1c and stx2b
O91:H21 NVI-967 QA - - stx2d
O128:H- E120 Sheep - - stx1d and stx2b
O146:H21 E382 Human - - stx1d and stx2b
O166:H15 NVI-2134 QA - - stx2d
O113:H4 NVI-3748 QA - - stx1c and stx2b
O146:H21 NVI-9954 QA - - stx2d
O157 2014-01-5652 Cattle - - stx2c

QA, quality assurance test strains obtained from the European reference laboratory for E. coli (Istituto Superiore di Sanità, Rome, Italy) or Statens Serum Institut (Copenhagen, Denmark). REF, reference strain. nd, not done.

Samples

As part of a nationwide prevalence survey of STEC in Swedish cattle, individual faecal and skin (ear) samples were collected at different slaughterhouses during 2011 to 2012. The total number of faecal and skin samples were 2041 and 418, respectively. Skin samples are likely to reflect bacteria previously shed by the individual animal as well as bacteria shed by other animals in the same group transferred via the environment or direct interaction e.g. grooming. They allow the efficient recovery of strains representative of a group of animals as they tend to be positive more often compared to individual faecal samples; the collection of ears for this purpose is easily standardized [17]. The number of samples collected at different slaughterhouses were determined to represent the geographical distribution of cattle in Sweden. In Norway, pooled faecal samples were collected through a nationwide survey sampling dairy herds with more than 50 cows in 2014 [18]. From each herd, faecal material was collected from ten different places, and were to include all present age groups. In total, samples were retrieved from 179 dairy herds.

Sample preparation and isolation of stx2a-positive E. coli

All samples were enriched in buffered peptone water at 37°C for 18–20 hours. After enrichment, DNA was extracted directly from the enrichment broths using QIAamp DNA Stool Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The extracted DNA was used for testing for the presence of Shiga toxin genes; stx1, stx2 and stx2a as described below. Isolation of stx2a-positive E. coli was attempted from all stx2a-positive samples, comprising plating onto different agar plates (i.e. MacConkey agar, Sorbitol MacConkey agar and/or CHROMagar O157) and incubation at 37°C overnight. Colonies with presumptive E. coli morphology were selected for further testing for presence of stx2a and DNA was extracted from colony material by boiling and tested by the stx2a real-time PCR. Presumptive stx2a-positive E. coli were confirmed as E. coli using MALDI-TOF-MS (Bruker, Bremen, Germany) and characterized by WGS as described below. Extracted DNA from a subset of cattle skin (ear) samples were subjected to high-throughput amplicon sequencing of stx2 genes.

Real-time PCR detection of stx genes

DNA extracts from all the enriched samples were subjected to screening by real-time PCR for the detection of stx1 and stx2 as described by Perelle et al. 2004 [16] and ISO/TS 13136:2012 [19] as well as for stx2a by the novel real-time PCR assay (Table 1). The PCR analyses were performed slightly differently in Sweden versus in Norway; In the Swedish lab, PCR was performed in 15 μL PCR-reaction volumes containing 333 nM of each primer, 100 nM of probe, 2 μL template DNA and PerfeCTa qPCR Toughmix with Low ROX (Quantabio, Beverly, MA). PCR was conducted with an ABI 7500 Fast thermocycler (Life Technologies, Carlsbad, CA) using the following thermal profile: 95°C for 3 minutes followed by 45 cycles of 95°C for 3 seconds and 60°C for 30 seconds at which fluorescence was measured. Samples were regarded as positive if they resulted in a Ct-value <45. In the Norwegian lab, PCR was performed in 20 μL PCR-reaction volumes containing 333 nM of each primer, 100 nM of probe, 5 μL template DNA and 10 μL Brilliant III Ultra-Fast QPCR Master Mix (Agilent Technologies, Santa Clara, CA). PCR was conducted with a Stratagene Mx3005P (Agilent technologies) using the following thermal profile: 95°C for 3 minutes followed by 45 cycles of 95°C for 3 seconds and 60°C for 30 seconds at which fluorescence was measured. Samples were regarded as positive if they resulted in a Ct-value <45.

High-throughput amplicon sequencing of stx2 genes from skin samples

To further estimate the prevalence of stx2 variants and combinations of variants, the sequencing protocol developed by Persson and co-workers [6,14] was adapted to the deep amplicon sequencing protocol provided by Illumina [20]. The modified primers are shown in Table 1. This assay was applied to DNA extracted from enrichment broths of a subset of 48 stx2 PCR-positive Swedish cattle skin (ear) samples. Amplicons generated using the modified primers were barcoded using Nextera XT index kit (Illumina, San Diego, CA). An Illumina MiSeq instrument was used for sequencing 250 base pairs in both directions. Primer sequences were removed and reads were quality trimmed using Trimmomatic 0.32 [21]. Any read pair with less than 200 bp of high quality sequence from each direction was discarded. Read pairs were mapped against 89 known stx2 variants [14], and the closest match for each read pair was determined. Samples were discarded if less than 100 read pairs were consistent with stx2, and any sequence variant supported by <5% of the total reads for a given sample was ignored to remove spurious variants generated by sequencing errors. With the minimum accepted length of 2 × 200 bp, all known variants could be unambiguously classified as either stx2 subtype a, b, c, d, e, f or g with the exception of the sequence variants AF500189 (stx2d, could not be distinguished from certain stx2c) and M59432 (stx2c, could not be distinguished from certain stx2a) which occurred in zero and one sample respectively.

Statistical analysis

Shiga toxin gene prevalence with 95% confidence intervals were calculated by the exact binomial test using R version 3.6.2 for Windows [22].

Whole genome sequencing of stx2a-positive E. coli isolates

DNA was extracted from stx2a-positive E. coli isolates with QIAmp DNA mini kit or using an EZ1 Biorobot with the DNA Tissue kit (Qiagen, Hilden, Germany). The Nextera XT Kit (Illumina, San Diego, CA) was used to prepare libraries. The Swedish isolates were sequenced on a MiSeq (Illumina, San Diego, CA) as paired-end 2×250 base pair reads and the Norwegian isolates were sequenced on a HiSeq 2500 instrument using rapid mode generating paired-end reads from each isolate in two lanes i.e. 2×2×250 base pair reads. All isolates were sequenced to >30 × depth. Quality control was performed using FastQC and sequence data was uploaded to the European Nucleotide Archive under project numbers PRJEB35296 and PRJEB38743 for the Swedish and Norwegian data respectively. Reads were trimmed and draft assemblies were generated using SPAdes 3.5.0.

Genomic characterization of stx2a-positive E. coli isolates

The phylogroup of the stx2a-positive E. coli isolates was determined by in silico implementation of the PCR system of Clermont et al. [23] on assembled genomes. Multilocus sequence typing (MLST) [24], in silico serotyping [25] and virulence gene detection [26] was performed using Centre for Genomic Epidemiology web services [27]. Clustering of MLST data was performed using the minimum spanning tree algorithm in Bionumerics 7.6 (Applied Maths NV, Sint-Martens-Latem, Belgium), with each locus as an equivalent categorical variable. Multiple correspondence analysis was performed on virulence gene presence/absence data in R 3.5.0 [22] using the FactoMineR library.

Results

Development of a real-time PCR for stx2a

The specificity of the novel PCR assay was confirmed at both laboratories by analyzing clinical and reference strains encoding stx1 and/or stx2. All 45 stx2a-positive strains and none of the 35 stx2a-negative strains were identified as stx2a-positive by the real-time PCR (Table 2). The PCR efficiency was calculated to be 75% based on the standard curve from serial dilutions of DNA from EDL933.

Detection of stx gene variants in cattle samples

Table 3 presents the prevalence, with their corresponding 95% confidence intervals, of the various stx genes in samples from the two cattle surveys in Sweden and Norway, respectively. In short, for skin (ear) samples taken in the Swedish survey the prevalence was 64.1%, 78.7% and 1.6% for stx1, stx2 and stx2a, respectively. The corresponding results for the faecal samples in Sweden were 37.2% for stx1, 52.9% for stx2 and 5.0% for stx2a. The herd prevalence detected from the pooled faecal samples in Norway were 79.3%, 93.9% and 16.8% for stx1, stx2 and stx2a, respectively.

Table 3. Prevalence of Shiga toxin genes (with 95% CI) in Swedish dairy cattle and Norwegian dairy herds using different sampling procedures.

Sample Total stx1 stx2 stx2a
n % (95% CI) n % (95% CI) n % (95% CI)
Sweden
skin 418 268 64.1 (59.3–68.7) 329 78.7 (74.5–82.5) 7 1.6 (0.7–3.4)
faecal 2041 760 37.2 (35.1–39.4) 1081 52.9 (50.8–55.1) 103 5.0 (4.1–6.1)
Norway
pooled faecal 179 142 79.3 (73.0–85.0) 168 93.9 (89.3–96.9) 30 16.8 (11.6–23.1)

Amplicon sequencing of a subset of Swedish stx2 PCR-positive skin broth samples produced high-quality output for 31 of 48 samples, revealing a high number of samples being positive for stx2a (71.0%) and stx2d (48.4%), with a lower proportion of samples positive for stx2c (9.7%), stx2g (9.7%), and stx2b (6.5%) (Fig 1A). Most samples were positive for only a single stx2 variant, but several were positive for two or three different variants, most commonly stx2a together with stx2d (Fig 1B). Only four out of the 22 samples in which stx2a was identified by amplicon sequencing were positive for stx2a when tested by real-time PCR.

Fig 1. Prevalence of Shiga toxin 2 variants in 31 stx2-positive skin samples from Swedish cattle evaluated by amplicon sequencing.

Fig 1

The figure shows (A) the prevalence, with 95% confidence intervals, of each stx2 variant and (B) combinations of different toxin variants found in individual samples.

Genomic characterization of stx2a-positive E. coli isolates

In total, 40 stx2a-positive E. coli isolates were retrieved from the Swedish (n = 25) and the Norwegian (n = 15) samples by plating the enriched samples onto selective agar plates and selecting one isolates per positive sample. One isolate was determined not to be stx2a-positive after genome analysis and excluded from further analysis, bringing the total number of included isolates to 39. Characteristics of the stx2a-positive E. coli isolates are summarized in Fig 2 and S1 Table. Most of the isolates belonged to phylogroup B1 (n = 27), but A (n = 8) and B2 (n = 3) were also represented. One isolate could not be assigned to a phylogroup as it presented an undefined profile (+/-/+/+). A total of 19 MLST profiles were identified, of which 11 profiles formed three clonal complexes (CC) centered around ST-10 (phylogroup A, CC10, 9 isolates), ST-223 (phylogroup B1, CC155, 7 isolates) and ST-718 (phylogroup B1, 10 isolates from different predefined and undefined CC’s). These three CC’s were recovered from both Swedish and Norwegian cattle (Fig 3). Isolates were assigned to a CC if they differed from one another by a maximum of three loci. In silico serotyping revealed substantial diversity but was generally in agreement with MLST and phylogroup divisions (Fig 2). Virulence gene detection revealed five isolates to be “classical” LEE-positive STEC with intimin (eae), tir, tccP and a repertoire of non-LEE encoded effector genes. These isolates were O121:H19 (ST-655), O26:H11 (ST-21), O84:H2 (ST-306, two isolates) and O101:H33 (ST-330). Notably, 36 of the 39 isolates were positive for haemolysin genes (ehxA). Multiple correspondence analysis supported the presence of a distinctive group of LEE-positive isolates and a second group of STEC/ETEC (enterotoxigenic E. coli) hybrids with heat-stable enterotoxin 1 (sta1) but lacking lpfA and espP among other traits (Fig 4). The latter group corresponded to the previously mentioned CC10 clonal complex. A single isolate in this complex (O101:H33 ST-330) was intermediate in being both LEE-positive and an STEC/ETEC hybrid.

Fig 2. Virulence gene profiles, sequence types, phylogroups and serotypes of 39 stx2a-positive E. coli isolates from cattle in Sweden and Norway.

Fig 2

Two outbreak strains of EHEC (O157:H7 TW14359 and O121:H19 16–9255) are included as references. U; undetermined phylogroup or sequence type. ONT; antigen non-typable. O2 not distinguishable from O50. O101 not distinguishable from O162. O153 not distinguishable from O178.

Fig 3. Minimum spanning tree of sequence types among stx2a-positive E. coli from cattle.

Fig 3

All three major clonal complexes comprise isolates of both Swedish (blue) and Norwegian (red) origin. A difference in only one SNP is displayed by a thick line whereas a difference in two SNP’s is displayed by a thin line.

Fig 4. Multiple correspondence analysis biplots of the virulence genes of stx2a-positive E. coli from Norwegian and Swedish cattle.

Fig 4

Association between virulence genes is estimated based on co-occurence in isolates (A), and association between isolates is estimated based on the genes they possess or lack (B).

Discussion

Prevalence of stx2 and stx2a in cattle

Shiga toxin-producing E. coli are generally considered a normal part of the healthy ruminant intestinal flora, so the high prevalence of both stx1 and stx2 genes observed among cattle in the present study is not surprising. As some STEC seem to be more associated with severe human infection than others, the general detection of stx genes without any knowledge of the subtypes present is not well suited for detecting severe human pathogens. The stx genes are encoded in prophage genomes, and free phage particles might increase the load of PCR-detectable stx genes in environments where stx-carrying bacteria are present. Both shedding and colonization status for ruminants with STEC can be expected to be periodic or transient; the presence of potential pathogens on the herd level can therefore be more relevant compared to the prevalence in individual animals.

In the Swedish survey, the skin (ear) samples resulted in higher prevalence’s than the corresponding faecal samples. This is in concordance with previous results from Sweden [17], and indicate that skin (ear) samples represents the prevalence in an animal herd or group and not individual animals. The Norwegian survey analyzed pooled faecal samples collected from dairy herds, giving herd prevalence and not individual which is probably the reason these resulted in the highest stx prevalence. Due to the differences in sampling and study design, the stx prevalence in the two countries cannot be compared directly. This was not the purpose of this study.

In recent years, studies have shown that STEC strains carrying stx2 are more pathogenic than those carrying only stx1, while STEC strains with the stx2a subtype are most frequently associated with severe STEC disease manifestation; HUS [4,6,7]. The association between stx2a and HUS made this subtype a particular focus of the presented study. As more STEC strains have been investigated by whole genome sequencing over the years it has been shown that there are sequence diversity within the stx2a subtype, with some variants being highly similar to sequence variants of the stx2c subtype [14]. In the present study, a novel real-time PCR assay was developed to specifically detect stx2a genes. This PCR was employed for primary screening of samples in order to identify samples for attempting isolation of stx2a-positive E. coli isolates from the two countries for further characterization. As specificity was the primary concern in the development of this PCR, the sensitivity is likely to be suboptimal and the PCR level prevalence of stx2a reported for the different sample types should be interpreted with caution. The poor sensitivity was a necessary trade-off to produce a sufficiently specific assay for identifying stx2a-positive samples due to the high sequence similarity of stx2a compared to other stx2 subtypes. The real-time PCR described here has successfully been employed in two different laboratories using different PCR reagents and platforms which indicates that the method is robust and can easily be used in different laboratories. As the real-time PCR has not been tested on spiked samples with known levels of stx2a-positive STEC we do not know how the Ct values relates to number of cells. We are, however, aware that a Ct-value of 45 might be a false positive. In the case of stx2a-positive STEC, we consider it more important to avoid false negative samples than having a few false positive samples.

A community profiling approach based on amplicon sequencing of partial stx2 genes was used on a subset of the stx2 PCR-positive samples. This revealed stx2a and stx2d to be the most common types of stx2 among Swedish cattle samples, but also the presence of several other variants and combinations of variants. With these results in mind, identifying all potential STEC in a sample, especially an environmental or primary production sample, one would need to retrieve and test several isolates. This is in line with recommendations in ISO/TS-13136:2012 [19]. It is also reasonable to believe that one or more stx1-subtypes, in addition to several stx2-subtypes, could be present in a sample as well as different strains with the same stx1- or stx2-subtype, e.g. stx2a could be present in two different genomic backbones in the same sample. However, this was beyond the scope of this study. The approach of using amplicon sequencing described in this study is a powerful tool for detecting all known stx2 variants in a sample, only limited by the inclusivity of the standard stx2 sequencing primers. A comparison between the real-time PCR and amplicon sequencing results revealed that only four out of 22 samples positive for stx2a by amplicon sequencing were also positive for the same subtype by PCR. Although the limit of detection for the PCR was low when evaluated using purified DNA from a defined strain this might not be the case for mixed samples where other subtypes of stx2 may interfere with the amplification. However, there might also be an actual difference in the analytical sensitivity between the two methods. The real-time PCR was primarily used in this study as a screening tool in order to retrieve stx2a-positive E. coli and therefore the discrepant results were not further investigated.

Characteristics and public health relevance of LEE-positive STEC isolates

Most STEC associated with HUS reported in the literature to date have carried stx2a genes in combination with the locus of enterocyte attachment and effacement (LEE) [28]. In the present study, only one LEE-positive isolate was detected from the Swedish samples; an O121:H19. STEC O121:H19 is a well-known cause of severe outbreaks and sporadic infections, and is a known HUSEC [4,29]. From the Norwegian samples one LEE-positive STEC of serotype O26:H11 was detected. This serotype is known to carry different variants of stx genes or to be stx-negative when isolated from ruminants, and stx2a-positive strains of O26:H11 have caused several cases of HUS in Norway [30] as well as elsewhere [31]. Two isolates of O84:H2 (ST-306) with LEE and harbouring both stx1 and stx2a genes were also recovered from the Norwegian samples. O84:H2 has been found in cattle and as a cause of sporadic cases of diarrhoea among humans in New Zealand [32], but has to our knowledge not been linked to severe cases of illness. However, strains of the same sequence type, ST-306, with different serotypes have been linked to HUS cases in both Germany [4] and Sweden [33].

Characteristics and public health relevance of LEE-negative STEC isolates

LEE-negative STEC are rare, but perhaps underestimated as a cause of HUS, as diagnostics have historically focused on the most well-known LEE-positive serotypes. In general, LEE-negative isolates rely on alternative host tissue adhesion mechanisms, which are either poorly understood or known, but historically associated with other E. coli pathotypes [911]. The most notable example of LEE-negative HUSEC is the major outbreak in Europe 2011 of enteroaggregative E. coli O104:H4 encoding stx2a [34], but smaller outbreaks and sporadic cases are continuously reported. Two variants of LEE-negative STEC recovered from Swedish cattle in the present study, O113:H21 (ST-223) and O130:H11 (ST-297), have caused sporadic cases of HUS in Sweden [35]. O113:H21 (ST-223) is a well-known LEE-negative HUSEC with cases reported from several countries [36], while O130:H11 has also been associated with HUS in Australia [37] and Argentina [9]. The presence of both of these strains in Swedish and Norwegian cattle thus should be considered a public health concern. Another potential HUSEC was an O163:H19, a serotype that has previously been linked to a case of HUS in the UK [38]. The remaining serotypes and STs found in the present study have not to our knowledge, been linked to severe illness in humans. However, several known LEE-negative HUSEC could not be distinguished from strains not known to cause HUS in terms of virulence gene repertoire (Fig 4), this might be due to the selection of genes included in this study which is biased towards LEE-positive STEC and other known pathotypes. Previous studies have had similar difficulties in identifying the virulence determinants of non-LEE HUSEC [39], but new potentially relevant markers are continuously being discovered [40].

STEC/ETEC hybrid isolates

In recent years, hybrid pathotypes of E. coli have been reported to be associated with diarrhea and HUS [32,3942]. Several isolates obtained in this study carried genes encoding heat-stable enterotoxin 1 (sta1) in addition to stx2a and can thus be considered hybrids between the STEC and ETEC (enterotoxigenic E. coli) pathotypes. The isolates appear to be related to some extent, belonging to phylogroup A and ST-10, but belonging to multiple serotypes with O2/O50:H27 being the most common. This lineage was found in isolates from both Norway and Sweden, and STEC/ETEC hybrids of matching serotypes have previously been isolated from patients and cattle in Italy and Finland [41,43]. A single isolate of ST-330 in the present study had both a LEE-region, the ETEC sta1 toxin and belonged to the same clonal complex as the ST-10 STEC/ETEC LEE-negative hybrids. A strain matching the description of the present finding (O101:H33, phylogroup A, ST-330, sta1+) have been associated with HUS in an infant in Finland in 2001 [44]; another isolate with matching phylogroup and ST, but no expressed serotype (ONT:H-), has been reported from a German HUS case [4].

Conclusions

In this study, we found a substantial proportion of stx2a-positive samples from Swedish and Norwegian cattle. stx2a and stx2d were the most common variants among Swedish cattle samples analyzed by high throughput amplicon sequencing, however other variants and combinations of variants were also seen. This approach of using amplicon sequencing is a powerful tool for detecting all known stx2 variants in a sample and reflects the importance of selecting more than one stx-positive isolate in a complex sample. Isolation and characterization of 39 stx2a-positive E. coli revealed that only a small proportion have similar virulence profiles as known HUSEC-strains and only a few known HUSEC lineages were identified among the stx2a-positive isolates. We conclude that stx2a-positive E. coli in cattle are ranging from strains similar to HUSEC to unknown STEC variants. It is currently unclear whether most stx2a-positive E. coli pose a risk of causing HUS in a vulnerable patient, or if this capability is an emergent property of combinations of other virulence factors including key adhesins. Due to this unexplored field it would be of interest to compare human and animal isolates further by comparative WGS analysis.

Supporting information

S1 Table. Virulence genes in stx2a isolates.

(XLSX)

Acknowledgments

The sequencing service for the Norwegian isolates was provided by the Norwegian Sequencing Centre (www.sequencing.uio.no), a national technology platform hosted by the University of Oslo and supported by the "Functional Genomics" and "Infrastructure" programs of the Research Council of Norway and the Southeastern Regional Health Authorities.

Data Availability

All raw data files are available from the ENA database (accession number(s) PRJEB35296 and PRJEB38743.

Funding Statement

The work performed in Sweden was funded by the Swedish Board of Agriculture and the Swedish Civil Contingencies Agency. The work performed in Norway was funded by The Research Council of Norway (Project no 221663; Pathogens in the food chain) and the Norwegian Veterinary Institute. The Norwegian samples were collected in a survey funded by the Norwegian Food Safety Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol. 2014. July;36(4):399–420. 10.1007/s00281-014-0416-x [DOI] [PubMed] [Google Scholar]
  • 2.Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS. Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol Berl Ger. 2013. November;28(11):2097–105. [DOI] [PubMed] [Google Scholar]
  • 3.Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bover-Cid S, Chemaly M, Davies R, et al. Pathogenicity assessment of Shiga toxin-producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC. EFSA J. 2020;18(1):e05967. [Google Scholar]
  • 4.Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, et al. Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli. Emerg Infect Dis. 2008. August;14(8):1287–90. 10.3201/eid1408.071082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tozzoli R, Grande L, Michelacci V, Ranieri P, Maugliani A, Caprioli A, et al. Shiga toxin-converting phages and the emergence of new pathogenic Escherichia coli: a world in motion. Front Cell Infect Microbiol [Internet]. 2014. June 20 [cited 2014 Nov 4];4 Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064290/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Persson S, Olsen KEP, Ethelberg S, Scheutz F. Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations. J Clin Microbiol. 2007. June;45(6):2020–4. 10.1128/JCM.02591-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brandal LT, Wester AL, Lange H, Løbersli I, Lindstedt B-A, Vold L, et al. Shiga toxin-producing escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome. BMC Infect Dis. 2015. August 11;15:324 10.1186/s12879-015-1017-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.KAPER JB, O’BRIEN AD. Overview and Historical Perspectives. Microbiol Spectr [Internet]. 2014. [cited 2020 Feb 28];2(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290666/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Galli L, Miliwebsky E, Irino K, Leotta G, Rivas M. Virulence profile comparison between LEE-negative Shiga toxin-producing Escherichia coli (STEC) strains isolated from cattle and humans. Vet Microbiol. 2010. July 14;143(2–4):307–13. 10.1016/j.vetmic.2009.11.028 [DOI] [PubMed] [Google Scholar]
  • 10.Newton HJ, Sloan J, Bulach DM, Seemann T, Allison CC, Tauschek M, et al. Shiga Toxin–producing Escherichia coli Strains Negative for Locus of Enterocyte Effacement. Emerg Infect Dis. 2009. March;15(3):372–80. 10.3201/eid1503.080631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Colello R, Vélez MV, González J, Montero DA, Bustamante AV, Del Canto F, et al. First report of the distribution of Locus of Adhesion and Autoaggregation (LAA) pathogenicity island in LEE-negative Shiga toxin-producing Escherichia coli isolates from Argentina. Microb Pathog. 2018. October;123:259–63. 10.1016/j.micpath.2018.07.011 [DOI] [PubMed] [Google Scholar]
  • 12.Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis. 2011. September;11(9):671–6. 10.1016/S1473-3099(11)70165-7 [DOI] [PubMed] [Google Scholar]
  • 13.Paton AW, Srimanote P, Woodrow MC, Paton JC. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun. 2001. November;69(11):6999–7009. 10.1128/IAI.69.11.6999-7009.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Scheutz F, Teel LD, Beutin L, Piérard D, Buvens G, Karch H, et al. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol. 2012. September;50(9):2951–63. 10.1128/JCM.00860-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Identification of the subtypes of Verocytotoxin encoding genes (vtx) of Escherichia coli by conventional PCR—EU-RL VTEC_Method_006_Rev 1 [Internet]. [cited 2018 Aug 14]. http://old.iss.it/binary/vtec/cont/EU_RL_VTEC_Method_06_Rev_1.pdf
  • 16.Perelle S, Dilasser F, Grout J, Fach P. Detection by 5’-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world’s most frequent clinical cases. Mol Cell Probes. 2004. June;18(3):185–92. 10.1016/j.mcp.2003.12.004 [DOI] [PubMed] [Google Scholar]
  • 17.Boqvist S, Aspan A, Eriksson E. Prevalence of verotoxigenic Escherichia coli O157:H7 in fecal and ear samples from slaughtered cattle in Sweden. J Food Prot. 2009. August;72(8):1709–12. 10.4315/0362-028x-72.8.1709 [DOI] [PubMed] [Google Scholar]
  • 18.Johannessen G, Sekse C, Hopp P, Urdahl AM. Rapport 15–2018 Zoonotiske E. coli hos storfe. ISSN 1890-3290. Veterinærinstituttet; 2018 (In Norwegian).
  • 19.ISO/TS-13136:2012: Microbiology of Food and Animal Feed. Real-Time Polymerase Chain Reaction (PCR)-Based Method for the Detection of Food-Borne Pathogens. Horizontal Method for the Detection of Shiga Toxin-Producing Escherichia coli (STEC) and the Determination of O157, O111, O26, O103 and O145 Serogroups. 2012.
  • 20.16S Metagenomic Sequencing Library Preparation—# 15044223 Rev. B [Internet]. [cited 2018 Aug 14]. https://support.illumina.com/documents/documentation/chemistry_documentation/16s/16s-metagenomic-library-prep-guide-15044223-b.pdf
  • 21.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinforma Oxf Engl. 2014. August 1;30(15):2114–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2019. http://www.R-project.org/ [Google Scholar]
  • 23.Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013. February;5(1):58–65. 10.1111/1758-2229.12019 [DOI] [PubMed] [Google Scholar]
  • 24.Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012. April;50(4):1355–61. 10.1128/JCM.06094-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Joensen KG, Tetzschner AMM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and Easy In Silico Serotyping of Escherichia coli Isolates by Use of Whole-Genome Sequencing Data. J Clin Microbiol. 2015. August;53(8):2410–26. 10.1128/JCM.00008-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, Nielsen EM, et al. Real-Time Whole-Genome Sequencing for Routine Typing, Surveillance, and Outbreak Detection of Verotoxigenic Escherichia coli. J Clin Microbiol. 2014. May 1;52(5):1501–10. 10.1128/JCM.03617-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Center for Genomic Epidemiology [Internet]. [cited 2018 Aug 14]. http://www.genomicepidemiology.org/
  • 28.Franzin FM, Sircili MP. Locus of Enterocyte Effacement: A Pathogenicity Island Involved in the Virulence of Enteropathogenic and Enterohemorragic Escherichia coli Subjected to a Complex Network of Gene Regulation. BioMed Res Int. 2015;2015:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Morton V, Cheng JM, Sharma D, Kearney A. An outbreak of Shiga toxin-producing Escherichia coli O121 infections associated with flour-Canada, 2016–2017†. Can Commun Dis Rep Releve Mal Transm Au Can. 2017. July 6;43(7–8):154–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Brandal LT, Sekse C, Lindstedt B-A, Sunde M, Løbersli I, Urdahl AM, et al. Norwegian sheep are an important reservoir for human-pathogenic Escherichia coli O26:H11. Appl Environ Microbiol. 2012. June;78(12):4083–91. 10.1128/AEM.00186-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Jenkins C, Evans J, Chart H, Willshaw GA, Frankel G. Escherichia coli serogroup O26 –a new look at an old adversary. J Appl Microbiol. 2008. January 1;104(1):14–25. 10.1111/j.1365-2672.2007.03465.x [DOI] [PubMed] [Google Scholar]
  • 32.Cookson AL, Croucher D, Pope C, Bennett J, Thomson-Carter F, Attwood GT. Isolation, Characterization, and Epidemiological Assessment of Shiga Toxin-Producing Escherichia coli O84 Isolates from New Zealand. J Clin Microbiol. 2006. May;44(5):1863–6. 10.1128/JCM.44.5.1863-1866.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bai X, Mernelius S, Jernberg C, Einemo I-M, Monecke S, Ehricht R, et al. Shiga Toxin-Producing Escherichia coli Infection in Jönköping County, Sweden: Occurrence and Molecular Characteristics in Correlation With Clinical Symptoms and Duration of stx Shedding. Front Cell Infect Microbiol [Internet]. 2018. [cited 2018 Aug 14];8 Available from: https://www.frontiersin.org/articles/10.3389/fcimb.2018.00125/full [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Karch H, Denamur E, Dobrindt U, Finlay BB, Hengge R, Johannes L, et al. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med. 2012. September;4(9):841–8. 10.1002/emmm.201201662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mikrobiell övervakning av ehec 2018—Kvartal 2 [Internet]. Public Health Agency, Sweden; [cited 2018 Aug 14]. https://www.folkhalsomyndigheten.se/contentassets/611f70ca205247ae9b5d7f4ce19c3293/mikrobiell-overvakning-ehec-2018kvartal2.pdf (In Swedish).
  • 36.Feng PCH, Delannoy S, Lacher DW, dos Santos LF, Beutin L, Fach P, et al. Genetic Diversity and Virulence Potential of Shiga Toxin-Producing Escherichia coli O113:H21 Strains Isolated from Clinical, Environmental, and Food Sources. Appl Environ Microbiol. 2014. August;80(15):4757–63. 10.1128/AEM.01182-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Elliott EJ, Robins-Browne RM, O’Loughlin EV, Bennett-Wood V, Bourke J, Henning P, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child. 2001. August;85(2):125–31. 10.1136/adc.85.2.125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Scotland SM, Rowe B, Smith HR, Willshaw GA, Gross RJ. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol. 1988. April;25(4):237–43. 10.1099/00222615-25-4-237 [DOI] [PubMed] [Google Scholar]
  • 39.Haugum K, Johansen J, Gabrielsen C, Brandal LT, Bergh K, Ussery DW, et al. Comparative Genomics to Delineate Pathogenic Potential in Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) from Patients with and without Haemolytic Uremic Syndrome (HUS) in Norway. PLoS ONE. 2014. October 31;9(10):e111788 10.1371/journal.pone.0111788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Montero DA, Velasco J, Del Canto F, Puente JL, Padola NL, Rasko DA, et al. Locus of Adhesion and Autoaggregation (LAA), a pathogenicity island present in emerging Shiga Toxin-producing Escherichia coli strains. Sci Rep. 2017. August 1;7(1):7011 10.1038/s41598-017-06999-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nyholm O, Heinikainen S, Pelkonen S, Hallanvuo S, Haukka K, Siitonen A. Hybrids of Shigatoxigenic and Enterotoxigenic Escherichia coli (STEC/ETEC) Among Human and Animal Isolates in Finland. Zoonoses Public Health. 2015. November;62(7):518–24. 10.1111/zph.12177 [DOI] [PubMed] [Google Scholar]
  • 42.Oh K-H, Shin E, Jung S-M, Im J, Cho S-H, Hong S, et al. First Isolation of a Hybrid Shigatoxigenic and Enterotoxigenic Escherichia coli Strain Harboring the stx2 and elt Genes in Korea. Jpn J Infect Dis. 2017;70(3):347–8. 10.7883/yoken.JJID.2016.237 [DOI] [PubMed] [Google Scholar]
  • 43.Michelacci V, Maugliani A, Tozzoli R, Corteselli G, Chiani P, Minelli F, et al. Characterization of a novel plasmid encoding F4-like fimbriae present in a Shiga-toxin producing enterotoxigenic Escherichia coli isolated during the investigation on a case of hemolytic-uremic syndrome. Int J Med Microbiol. 2018. October;308(7):947–55. 10.1016/j.ijmm.2018.07.002 [DOI] [PubMed] [Google Scholar]
  • 44.Nyholm O, Halkilahti J, Wiklund G, Okeke U, Paulin L, Auvinen P, et al. Comparative Genomics and Characterization of Hybrid Shigatoxigenic and Enterotoxigenic Escherichia coli (STEC/ETEC) Strains. PLOS ONE. 2015. August;10(8):e0135936 10.1371/journal.pone.0135936 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Patrick Butaye

22 May 2020

PONE-D-20-09947

The prevalence and genomic context of Shiga toxin 2a genes in E. coli  found in cattle

PLOS ONE

Dear Dr. Sekse,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has been well received by the reviewers, though there are some remarks that need to be addressed. Please go over all of them and adapt where appropriate.

Please submit your revised manuscript by Jul 06 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Patrick Butaye, DVM, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Well-written and interesting paper, only a few minor concerns

L24 skin samples needs more explanation - as initially guessed rectal biopsy

L28 and elsewhere in manuscript - Need to be careful describing isolates as HUSEC. Your cattle isolates might be similar to those which have caused HUSEC, but at present still no absolute way of determining which isolates will cause human disease.

Would instead use "strains similar to HUSEC" to make this distinction. If we could perfectly identify HUSEC, would not be a need for your study, but as stated on L 33 we are working towards being able to identify HUSEC (not there yet).

L30 ST=sequence type? Needs to be defined

L31 same problem as on L28

L45 previously associated with HUS

Table 1 Some interesting nucleotides in these primers. Only familiar with A, C, T, and G. What are Y, W, and R? More description needed here.

L101 Having so much stx appearing in the ear is interesting. A bit more discussion about the use of the ear for sampling would be welcome. We have taken swabs of various parts of bovine anatomy to find STEC, but never considered the ear.

L326 Would suggest deleting 'finding that also represent a'

Reviewer #2: PONE-D-20-09947

The authors describe a study carried out in Sweden and Norway to assess the prevalence of shiga-toxin genes of clinical importance in cattle. While the study is of interest I do not think that in its current form it is not suitable for inclusion in PLOS one without considerable revision.

Introduction – Good introduction using relevant reference.

Methods – Authors have used appropriate methods for analysing the sample tested.

Line 120- further details of skin sampling required.

Line 137- was any attempt made to confirm that the sensitivity of these assays.

Line 139- why adopt different methods for analysing different samples- explain.

Results

You have used a ct value of <45 to indicate a positive sample. Do you know how this relates to cell numbers in this sample, which will contain a mixture of DNA from many different bacterial species present in the sample?

Is there agreement between the levels of stx2a detected by amplicon sequencing and RT-PCR?

Line 168 missing reference -xxxx

Line 199-201 makes me concerned about the sensitivity of this RT-PCR do you have another explanation.

Line 213 It is likely that the low recovery rate relates to the method used as if performed as described in the methods it is likely that many different E. coli and other bacteria will be growing on the plates and identifying the stx positive ones very difficult.

Figure 1a error bars are higher than the axis

Figure 2 can’t read poor quality.

Discussion

Line 269 remove either

Line 279 Please explain why sensitivity is not important?

Line 289 it’s essential to also consider that although stx gene are detected in a sample they may not be associated with E. coli. Consider the presence of free-phage.

Line 320 has any attempt been made to compare the genomes of these isolates if available.

Line 330 consider using other databases to identify virulence determinants if the one used is bias towards LEE. Did you search you genomes for genes discussed in ref 41.

Line 350 how do you determine significance.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 12;15(8):e0232305. doi: 10.1371/journal.pone.0232305.r002

Author response to Decision Letter 0


2 Jul 2020

A copy of the reply to reviewers can be found as a uploaded file, but also pasted in here;

Reply to reviewers

Thank you for comments and suggestions for improving the manuscript. We have tried to answer each comments as good as we can in this response to the reviewers comments.

Reviewer #1: Well-written and interesting paper, only a few minor concerns

L24 skin samples needs more explanation - as initially guessed rectal biopsy

Answer: We have added (ear) to the description of skin samples in the abstract and explained about the skin samples in the materials and methods (L105-109).

L28 and elsewhere in manuscript - Need to be careful describing isolates as HUSEC. Your cattle isolates might be similar to those which have caused HUSEC, but at present still no absolute way of determining which isolates will cause human disease.

Would instead use "strains similar to HUSEC" to make this distinction. If we could perfectly identify HUSEC, would not be a need for your study, but as stated on L 33 we are working towards being able to identify HUSEC (not there yet).

Answer: We totally agree with the reviewer that naming animal isolates as human pathogenic or HUSEC as there is not possible to determine whether they are true human pathogenic or not. We have changed from LEE-positive HUSEC to “LEE-positive strains similar to HUSEC”.

L30 ST=sequence type? Needs to be defined

Answer: We have defined ST as sequence type in L30.

L31 same problem as on L28

Answer: We have changed to “Lineages known to include LEE-negative HUSEC were also recovered including, such as O113:H21 (sequence type (ST)-223), O130:H11 (ST-297), and O101:H33 (ST-330).” in L29-L31 and to ”strains similar to HUSEC” in L32.

L45 previously associated with HUS

Answer: We have added “previously” to L46.

Table 1 Some interesting nucleotides in these primers. Only familiar with A, C, T, and G. What are Y, W, and R? More description needed here.

Answer: These nucleotides are degenerated bases and represent two binding alternatives and not only one as for A, C, T, G. We have included a description of the degenerate base symbols as a note to Table 1, L92. The codes used are standard as defined by IUPAC.

L101 Having so much stx appearing in the ear is interesting. A bit more discussion about the use of the ear for sampling would be welcome. We have taken swabs of various parts of bovine anatomy to find STEC, but never considered the ear.

Answer: Faecal shedding of STEC seems to be intermittent and often limited to a fraction of the animals in a group. In contrast, skin samples will likely represent an “archive” of recent shedding from the individual animal and other animals in the group. In O157:H7 studies we have found far more positive samples using ears compared to faeces collected in parallel. Therefore, we consider skin samples a cost-effective way of sampling if the goal is to collect as many isolates as possible rather than determining the individual prevalence. Various rubbing, grooming, eating, drinking etc. behaviours are likely to lead to bacteria being transferred to the head of the animal. Compared to other types of skin samples, ears are easy to collect in a standardized manner for the regular slaughterhouse staff. We have expanded the relevant part of the materials and methods section explaining this (L105-L109).

L326 Would suggest deleting 'finding that also represent a'

Answer: We agree and have deleted this and changed from suspected to “potential HUSEC”

Reviewer #2: PONE-D-20-09947

The authors describe a study carried out in Sweden and Norway to assess the prevalence of shiga-toxin genes of clinical importance in cattle. While the study is of interest I do not think that in its current form it is not suitable for inclusion in PLOS one without considerable revision.

Introduction – Good introduction using relevant reference.

Methods – Authors have used appropriate methods for analysing the sample tested.

Line 120- further details of skin sampling required.

Answer: We have added some details regarding the ear sampling and why this is done. (L105-L109) See also the response to Reviewer 1 above.

Line 137- was any attempt made to confirm that the sensitivity of these assays.

Answer: There was not performed spiking experiments with known number of Stx2-encoding bacteria to confirm the sensitivity of these assays. We are also aware that it might not be accurate enough to estimate limit of detection from the standard curve based on serial dilutions from a positive control, so we suggest to rewrite the following;

L87; “PCR efficiency was assessed by analysing serial dilutions of DNA from the positive control EDL933 in the Swedish lab”.

L189-L191; “The PCR efficiency was calculated to be 75% based on the standard curve from serial dilutions of DNA from EDL933.”

As we already stated in the discussion, this real-time PCR was primarily used as a screening tool to retrieve stx2a-positive E. coli.

Line 139- why adopt different methods for analysing different samples- explain.

Answer: The method is mainly the same, but we are using different qPCR mastermix. The reason for that is because the two different labs usually prefer the mastermix used and therefore have stocks of this available. We also recognize that we have used different sample volumes which might have an impact on the detection. As this might be of importance for assessing the PCR results. Although we have only tested the method in two laboratories using different PCR reagents and platforms, the results indicate that the method is robust and can easily be used in different laboratories. We have included a paragraph regarding this in the discussion (L290-293).

Results

You have used a ct value of <45 to indicate a positive sample. Do you know how this relates to cell numbers in this sample, which will contain a mixture of DNA from many different bacterial species present in the sample?

Answer: Since spiking experiments with known levels of stx2a has not been carried out, we do not know how the Ct-value relates to the number of cells in this PCR. We are, however, aware that a Ct-value at 45 might be a false positive. In the case of STEC we consider it more important to avoid false negatives than having a few false positive sample. We have included this in the discussion (L293-296).

Is there agreement between the levels of stx2a detected by amplicon sequencing and RT-PCR?

Answer: Unfortunately, neither method is well suited for quantitative analysis. The real-time PCR is designed to be specific at the cost of sensitivity and has low amplification efficiency. This is due to theoretical constraints from the high sequence similarity of stx2a to other stx2-subtypes. For amplicon sequencing we can exactly count the number of occurrences of each variant in the sample after PCR amplification and library generation, but this amplification is carried out using degenerate primers and is unlikely to have the same efficiency for different stx subtypes. We discussed using digital PCR, but again the low efficiency of the stx2a PCR would likely be a problem, in this case for endpoint signal thresholding.

Line 168 missing reference –xxxx

Answer: The reference in L168 is now added; PRJEB38743.

Line 199-201 makes me concerned about the sensitivity of this RT-PCR do you have another explanation.

Answer: As mentioned above and in the manuscript itself, the sensitivity of the PCR is indeed likely to be suboptimal. This is not a design flaw but a necessary trade-off given the small differences between stx2-subtypes; it was originally designed to verify isolates as stx2a-positive. Here we also use it to screen samples for selecting those with a decent chance of isolating stx2a-positive strains by randomly selecting E. coli colonies. For this purpose specificity is again more important as we are only interested in strongly positive and true positive samples. It is therefore not surprising that the amplicon sequencing assay picks up more positive samples overall in this case, although we do not believe it is more sensitive as a detection technique in general.

Line 213 It is likely that the low recovery rate relates to the method used as if performed as described in the methods it is likely that many different E. coli and other bacteria will be growing on the plates and identifying the stx positive ones very difficult.

Answer: The low recovery rate could definitively be due to high E. coli diversity and mainly other E. coli growing on the plates and therefore very difficult to identify the stx2a-positive bacteria. Another alternative might be colony hybridization with a specific probe, however, due to background noise this might not be a better option. Colony hybridization might require a copy of the plates for later selecting the stx positive colonies and would probably be more time consuming.

Figure 1a error bars are higher than the axis

Answer: The first author has access to the original figure 1a and are unfortunately on vacation at the moment. However, as soon as he is back we will upload a corrected Figure 1a. Hope that is acceptable for editor and the reviewer.

Figure 2 can’t read poor quality.

Answer: To the authors’ knowledge the quality of figure 2 is of sufficient quality when downloading the figure separately. The figure have been uploaded to PACE (https://pacev2.apexcovantage.com/) before submission to ensure that the figure meets PLOS One requirement. However, we have uploaded the original figure 2 which is in a wrong file format to see if that could help regarding the quality.

Discussion

Line 269 remove either

Answer: We have removed “either”.

Line 279 Please explain why sensitivity is not important?

Answer: We have added a sentence further explaining why sensitivity could not be prioritized (L288-290).

Line 289 it’s essential to also consider that although stx gene are detected in a sample they may not be associated with E. coli. Consider the presence of free-phage.

Answer: This is mentioned in the first paragraph of the discussion as a possible reason for PCR-positive samples. However, free phages are likely more of a concern in studies where samples are directly analysed by PCR, in the present study all samples are pre-enriched amplifying prophage stx genes.

Line 320 has any attempt been made to compare the genomes of these isolates if available.

Answer: Unfortunately we do not have access to genome data from the human isolates.

Line 330 consider using other databases to identify virulence determinants if the one used is bias towards LEE. Did you search you genomes for genes discussed in ref. 41?

Answer: To the authors’ knowledge virulence databases are difficult to interpret as many genes are virulence-associated or fitness genes, but not enough to cause disease alone. The people curating such databases need to have in depth knowledge about virulence genes and to our knowledge we are not aware of any virulence databases covering these new potential virulence-associated genes. We did not test specific virulence-associated genes as those referred to in ref. 41.

Line 350 how do you determine significance.

Answer: ”Significant” in a colloquial sense; we have now replaced the word with “substantial”.

Attachment

Submitted filename: Reply_to_reviewers_20200107.docx

Decision Letter 1

Patrick Butaye

21 Jul 2020

The prevalence and genomic context of Shiga toxin 2a genes in E. coli  found in cattle

PONE-D-20-09947R1

Dear Dr. Sekse,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Patrick Butaye, DVM, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Virulence genes in stx2a isolates.

    (XLSX)

    Attachment

    Submitted filename: Reply_to_reviewers_20200107.docx

    Data Availability Statement

    All raw data files are available from the ENA database (accession number(s) PRJEB35296 and PRJEB38743.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES